ReviewInternational journal of hematologic oncology2022

The effect of comorbidities on the choice of tyrosine kinase inhibitors in patients with chronic myeloid leukemia.

Guray Saydam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.